
Lumi's ''full stack'' precision medication manage platform accelerates, improves, and scales clinical decisions on medication selection and dosage. Our platform helps physicians optimize combination medication therapy through a systematic, measurable process, rather than the ''trial and error'' approach used today. Our initial focus is on the 99% of Heart Failure patients who are on incorrect or suboptimal medication therapy.

Lumi's ''full stack'' precision medication manage platform accelerates, improves, and scales clinical decisions on medication selection and dosage. Our platform helps physicians optimize combination medication therapy through a systematic, measurable process, rather than the ''trial and error'' approach used today. Our initial focus is on the 99% of Heart Failure patients who are on incorrect or suboptimal medication therapy.
Sector: AI-enabled medication management for heart failure
Headquarters: Washington, District of Columbia
Founders / Leadership: Fahad Rahman (Co-founder & CEO); Yvonne Moyer (Co-founder & CTO)
Platform: Lumi Intelligent Care (medication selection and dosage optimization)
Funding: Pre-Seed (lead: HeartX); total disclosed ~$150,000
Medication management and optimization for heart failure patients
Health technology / Digital health
150000.00 USD
Reported as a single pre-seed round; Crunchbase lists HeartX as lead investor.
“HeartX lead on pre-seed”